Insider Trading History of Auchincloss Thomas G

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Auchincloss Thomas G since 2006. This trader's CIK number is 1377820. At the time of last reporting, Auchincloss Thomas G was the Director of Concert Pharmaceuticals, Inc.. (stock ticker symbol CNCE). Also see all insider trading activities at Concert Pharmaceuticals, Inc..

Note that in the past Auchincloss Thomas G also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Yield10 Bioscience, Inc. (MBLX) by Auchincloss Thomas G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 MBLX 0 $0 40,865 $981,454 40,865 $134,854
2006 MBLX 1,000 $14,000 0 $0 0 $0

Yearly summary of insider trading at Concert Pharmaceuticals, Inc. (CNCE) by Auchincloss Thomas G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 CNCE 6,000 $28,500 0 $0 0 $0
2020 CNCE 2,500 $23,682 0 $0 0 $0
2018 CNCE 2,000 $23,431 0 $0 0 $0


Insider trading activities at 2 companies by Auchincloss Thomas G:

1. Yield10 Bioscience, Inc. (MBLX)

2. Concert Pharmaceuticals, Inc. (CNCE)

Table 1. Insider trading of Yield10 Bioscience, Inc. (MBLX) by Auchincloss Thomas G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-06-28 MBLX Sale 40,865 24.02 981,454
2007-06-28 MBLX Option Ex 40,865 3.30 134,854
2006-11-10 MBLX Buy 1,000 14.00 14,000

Table 2. Insider trading of Concert Pharmaceuticals, Inc. (CNCE) by Auchincloss Thomas G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-06-06 CNCE Buy 6,000 4.75 28,500
2020-03-12 CNCE Buy 1,500 8.52 12,772
2020-02-03 CNCE Buy 1,000 10.91 10,910
2018-11-15 CNCE Buy 1,000 11.50 11,500
2018-11-14 CNCE Buy 1,000 11.93 11,931

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Auchincloss Thomas G (Director of Concert Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.